750 related articles for article (PubMed ID: 14763913)
1. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy.
Golgeli A; Tanriverdi F; Suer C; Gokce C; Ozesmi C; Bayram F; Kelestimur F
Eur J Endocrinol; 2004 Feb; 150(2):153-9. PubMed ID: 14763913
[TBL] [Abstract][Full Text] [Related]
2. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
Tanriverdi F; Yapislar H; Karaca Z; Unluhizarci K; Suer C; Kelestimur F
Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522
[TBL] [Abstract][Full Text] [Related]
5. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone deficiency due to sports-related head trauma is associated with impaired cognitive performance in amateur boxers and kickboxers as revealed by P300 auditory event-related potentials.
Tanriverdi F; Suer C; Yapislar H; Kocyigit I; Selcuklu A; Unluhizarci K; Casanueva FF; Kelestimur F
Clin Endocrinol (Oxf); 2013 May; 78(5):730-7. PubMed ID: 22994791
[TBL] [Abstract][Full Text] [Related]
7. Sleep architecture in Sheehan's syndrome before and 6 months after growth hormone replacement therapy.
Ismailogullari S; Tanriverdi F; Kelestimur F; Aksu M
Psychoneuroendocrinology; 2009 Feb; 34(2):212-219. PubMed ID: 18930599
[TBL] [Abstract][Full Text] [Related]
8. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
9. Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement.
Hána V; Prázný M; Marek J; Skrha J; Justová V
Eur J Endocrinol; 2002 Sep; 147(3):333-7. PubMed ID: 12213670
[TBL] [Abstract][Full Text] [Related]
10. The effects of severe growth hormone deficiency on the skin of patients with Sheehan's syndrome.
Borlu M; Tanriverdi F; Koc CA; Unluhizarci K; Utas S; Kelestimur F
J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):199-204. PubMed ID: 17243955
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
Rizzo M; Trepp R; Berneis K; Christ ER
Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
[TBL] [Abstract][Full Text] [Related]
12. One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.
Boschetti M; Agosti S; Albanese V; Casalino L; Teti C; Bezante GP; Brunelli C; Albertelli M; Ferone D
Endocrine; 2017 Feb; 55(2):573-581. PubMed ID: 27075720
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
14. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
15. Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.
Skjaerbaek C; Vahl N; Frystyk J; Hansen TB; Jørgensen JO; Hagen C; Christiansen JS; Orskov H
Eur J Endocrinol; 1997 Aug; 137(2):132-7. PubMed ID: 9272100
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
[TBL] [Abstract][Full Text] [Related]
17. The effects of 12 months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency.
Tanriverdi F; Eryol NK; Atmaca H; Unluhizarci K; Ozdogru I; Sarikaya I; Bayram F; Kelestimur F
Clin Endocrinol (Oxf); 2005 Jun; 62(6):706-12. PubMed ID: 15943833
[TBL] [Abstract][Full Text] [Related]
18. Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiency.
Boschetti M; Casu M; Moretti S; Teti C; Albanese V; Albertelli M; Murialdo G; Minuto F; Ferone D
Hormones (Athens); 2015; 14(1):134-41. PubMed ID: 25402370
[TBL] [Abstract][Full Text] [Related]
19. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.
Janssen JA; van der Toorn FM; Hofland LJ; van Koetsveld P; Broglio F; Ghigo E; Lamberts SW; Jan van der Lely A
Eur J Endocrinol; 2001 Dec; 145(6):711-6. PubMed ID: 11720895
[TBL] [Abstract][Full Text] [Related]
20. Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study.
Curtò L; Giovinazzo S; Alibrandi A; Campennì A; Trimarchi F; Cannavò S; Ruggeri RM
Eur J Endocrinol; 2015 May; 172(5):543-52. PubMed ID: 25646405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
